Look inside the largest spatial omics dataset in oncology

We are making a 100-patient sample from the larger MOSAIC dataset (7,000 patients) available to researchers. We call this MOSAIC-Window.

Register your interest in MOSAIC-window

Benefits

Disease Biology Illustration

Work with cutting edge modalities such as spatial omics and single-cell data

Patient Subtypes

Run spatial omics proof-of-concepts before moving to larger projects

Harness spatial omics data for a greater chance of clinical success

  • New therapeutic targets for cancer indications
  • New patient subgroups
  • New diagnostic and prognostic biomarkers
  • New treatment response and resistance mechanisms
Patients
7,000
Patients
100
Cancer indications
NSCLC, Ovarian, Bladder, Mesothelioma, Glioblastoma, Breast Cancer, DLBCL
Cancer indications
Glioblastoma, Ovarian, Bladder
Data modalities
Spatial Transcriptomics, Single-Cell RNA-Seq, Bulk RNA-Seq, Clinical data, WES, H&E
Data modalities
Spatial Transcriptomics, Single-Cell RNA-Seq, Bulk RNA-Seq, Clinical data, WES, H&E

How does MOSAIC-Window work?

time-pointtime-point
time-pointtime-point
time-pointtime-point
time-pointtime-point
Step 1
Researchers in academia and industry can apply to access the MOSAIC-Window dataset
Step 2
Applications are subject to approval by Owkin and the MOSAIC partners
Step 3
Run your research project using the data
Step 4
Resulting publications will cite MOSAIC and its partners
Register your interest in MOSAIC-window